Therefore, the current study aimed at molecular characterization of NKG2D-dependent immune escape and development of a procedure to restore NKG2D-dependent immunosurveillance in HNSCC patients. The gene discussed is KLRK1; the disease is head and neck squamous cell carcinoma.